WallStreetZenWallStreetZen

NASDAQ: XERS
Xeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xeris Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Beth HechtChief Legal Officer and Corporate Secretary2025-12-0116,667$7.01
$116.79kSell
John Patrick Shannon Jr.Chief Executive Officer and Director2025-11-1487,100$1.55
$135.01kBuy
John Patrick Shannon Jr.Chief Executive Officer and Director2025-11-138,970$1.55
$13.90kBuy
John Patrick Shannon Jr.Chief Executive Officer and Director2025-11-1323,242$7.46
$173.41kSell
Beth HechtChief Legal Officer and Corporate Secretary2025-11-1116,667$7.40
$123.30kSell
Kevin McCullochPresident and Chief Operating Officer2025-10-02733$8.31
$6.09kSell
Marla PerskyDirector2025-09-1115,500$7.72
$119.61kSell
Jeffrey W. ShermanDirector2025-08-2847,040$6.66
$313.29kBuy
Jeffrey W. ShermanDirector2025-08-2842,232$7.92
$334.52kSell
John JohnsonDirector2025-08-13107,500$7.32
$786.47kSell

1 of 4

XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XERS insiders and whales buy or sell their stock.

XERS Shareholders

What type of owners hold Xeris Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.19%11,927,699$85.52MInstitution
Vanguard Group Inc5.92%9,827,917$70.47MInstitution
D E Shaw Co Inc3.52%5,839,886$41.87MInstitution
Redmile Group LLC3.26%5,413,284$38.81MInsider
Geode Capital Management LLC2.50%4,140,174$29.69MInstitution
Paul R. Edick2.33%3,868,354$27.74MInsider
State Street Corp2.25%3,738,329$26.80MInstitution
Qube Research Technologies Ltd1.97%3,274,834$23.48MInstitution
Morgan Stanley1.94%3,219,701$23.09MInstitution
Nuveen LLC1.70%2,827,874$20.28MInstitution

1 of 3

XERS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XERS58.40%14.81%Net SellingNet Buying
CAPR27.03%72.97%Net Buying
ALMS74.71%25.12%Net BuyingNet Buying
XNCR72.07%27.93%Net Selling
TYRA62.03%37.97%Net BuyingNet Selling
View Top Biotech Stocks

Xeris Biopharma Holdings Stock Ownership FAQ

Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings (NASDAQ: XERS) is owned by 58.40% institutional shareholders, 14.81% Xeris Biopharma Holdings insiders, and 26.79% retail investors. Redmile Group LLC is the largest individual Xeris Biopharma Holdings shareholder, owning 5.41M shares representing 3.26% of the company. Redmile Group LLC's Xeris Biopharma Holdings shares are currently valued at $38.81M.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.